Insider trade

Officer received an award of 444K GDRX derivative securities

Traded Mar 3, 2026 · Filed Mar 6, 2026

Goodrx HoldingsGDRX

444K
Derivative units

Why it stands out

Compensation award — excluded from discretionary-purchase analysis.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Mar 3, 2026
Reporting period: Not applicable
Filed with the SEC: Mar 6, 2026

OfficerGrant / award

Context

Classification

grant award

Code A — grant or award

Planned / mechanical clue

Footnote references vesting of compensation awards

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001809519-26-000048
Filed / recorded

Mar 6, 2026, 1:11 AM UTC

Added to OQRO

Oct 7, 2026, 5:51 AM UTC

Parser

form4-xml-v2

Data quality

Verified: identifiers matched exactly

Issuer

GoodRx Holdings, Inc.

Issuer CIK

1809519

Ticker

GDRX

Reporting person

Christopher A Mcginnis

Relationship

Officer

Officer title

See Remarks

Security

Restricted Stock Unit

Table

Derivative (Table II)

Transaction date

Mar 3, 2026

Transaction code

A

Shares / units

443,852

Price per share

$0.00

Acquired / disposed

Acquired (A)

Shares owned after

443,852

Ownership form

Direct

Amendment

No

Footnotes from the filing

Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
The restricted stock units will vest ratably in 12 equal quarterly installments, with the first vesting occurring on April 15, 2026, and subject to continued service through each applicable vesting date.